Social Life Network (OTC: WDLF) Files $40,000,000 Complaint in The United States District Court for the Southern District of California
April 19, 2021 22:58 ET | Social Life Network, Inc.
LOS ANGELES, CA, April 19, 2021 (GLOBE NEWSWIRE) -- Social Life Network, Inc. (OTC: WDLF), announces today that it has filed a $40,000,000 complaint against a convertible debt funder for multiple...
Nokia and Lenovo con
Nokia and Lenovo conclude patent cross-licensing agreement
April 07, 2021 03:26 ET | Nokia Oyj
Press Release Nokia and Lenovo conclude patent cross-licensing agreement 7 April 2021 Espoo, Finland – Nokia and Lenovo conclude patent cross-licensing agreement. Nokia announced today that it...
Nokia and Samsung si
Nokia and Samsung sign patent licensing agreement for video standards
March 11, 2021 01:00 ET | Nokia Oyj
Press Release Nokia and Samsung sign patent licensing agreement for video standards         Agreement covers use of Nokia’s inventions in video standards           11 March 2021 Espoo, Finland –...
Press release Oncology Venture signs agreement to out-license two pipeline assets as part of prioritized portfolio strategy
June 29, 2020 02:30 ET | Oncology Venture A/S
Hørsholm, Denmark (29 June 2020) – Oncology Venture A/S (“OV” or the “Company”) today announced that it has signed a definitive agreement out-licensing two clinical pipeline assets, LiPlaCis® and...
Oncotelic Logo.png
Mateon Announces Achievement of Milestone Under Licensing of OT-101/IL-2 Combination to Autotelic BIO
June 10, 2020 08:00 ET | Mateon Therapeutics
The licensing agreement of OT-101 to Autotelic BIO with the field of use limited to OT-101 (Trabedersen) with Interleukin-2 (OT-101/IL-2) combination became effective this week with the completion of...
NewLink Genetics Corporation logo
NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for Development of and Rights to Commercialization of NLG207
December 23, 2019 16:05 ET | NewLink Genetics Corporation
AMES, Iowa, Dec. 23, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the company has entered into an exclusive worldwide license agreement with Ellipses...
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China
July 10, 2019 16:01 ET | MacroGenics, Inc.
ROCKVILLE, MD, and SHANGHAI, China, July 10, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative...
ChromaDex logo
ChromaDex Corp. and Nestlé Health Science Enter Global Commercial License and Supply Agreement for TRU NIAGEN®
December 20, 2018 16:05 ET | ChromaDex Corporation
LOS ANGELES, Dec. 20, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today it entered into a license and supply agreement with Nestlé Health Science (NHSc), a global leader...
The Premiere Group Acquires Derek Lam Beauty License
December 11, 2018 09:05 ET | The Premiere Group
New York, New York, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The Premiere Group, a wholly owned subsidiary of the Perfume Center of America Inc., has acquired the Derek Lam Beauty license, in a multi-year...
MacroGenics and Zai Lab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Margetuximab, MGD013 and TRIDENT™ Molecule in Greater China
November 29, 2018 07:30 ET | MacroGenics, Inc.
Comprehensive collaboration across three MacroGenics’ pipeline programs to accelerate and expand ongoing developmentExpand Zai Lab’s late-stage clinical pipeline with margetuximab and obtain rights to...